Panbela Therapeutics (PBLA) Competitors $0.39 -0.02 (-3.70%) As of 03/18/2025 10:14 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends PBLA vs. PWUP, CELZ, AIMD, VAXX, ENSC, NLSP, ALBT, PBM, EVOK, and SNGXShould you be buying Panbela Therapeutics stock or one of its competitors? The main competitors of Panbela Therapeutics include PowerUp Acquisition (PWUP), Creative Medical Technology (CELZ), Ainos (AIMD), Vaxxinity (VAXX), Ensysce Biosciences (ENSC), NLS Pharmaceutics (NLSP), Avalon GloboCare (ALBT), Psyence Biomedical (PBM), Evoke Pharma (EVOK), and Soligenix (SNGX). These companies are all part of the "pharmaceutical products" industry. Panbela Therapeutics vs. PowerUp Acquisition Creative Medical Technology Ainos Vaxxinity Ensysce Biosciences NLS Pharmaceutics Avalon GloboCare Psyence Biomedical Evoke Pharma Soligenix Panbela Therapeutics (NASDAQ:PBLA) and PowerUp Acquisition (NASDAQ:PWUP) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations, community ranking and risk. Is PBLA or PWUP more profitable? Company Net Margins Return on Equity Return on Assets Panbela TherapeuticsN/A N/A -302.61% PowerUp Acquisition N/A N/A N/A Do institutionals & insiders hold more shares of PBLA or PWUP? 4.4% of Panbela Therapeutics shares are held by institutional investors. Comparatively, 19.2% of PowerUp Acquisition shares are held by institutional investors. 0.0% of Panbela Therapeutics shares are held by company insiders. Comparatively, 48.0% of PowerUp Acquisition shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community favor PBLA or PWUP? Panbela Therapeutics received 18 more outperform votes than PowerUp Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformPanbela TherapeuticsOutperform Votes1862.07% Underperform Votes1137.93% PowerUp AcquisitionN/AN/A Do analysts rate PBLA or PWUP? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Panbela Therapeutics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50PowerUp Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, PBLA or PWUP? Panbela Therapeutics has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500. Comparatively, PowerUp Acquisition has a beta of 0.05, meaning that its stock price is 95% less volatile than the S&P 500. Which has preferable earnings & valuation, PBLA or PWUP? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPanbela TherapeuticsN/AN/A-$25.26M-$71.13-0.01PowerUp AcquisitionN/AN/AN/AN/AN/A Does the media prefer PBLA or PWUP? In the previous week, Panbela Therapeutics' average media sentiment score of 0.00 equaled PowerUp Acquisition'saverage media sentiment score. Company Overall Sentiment Panbela Therapeutics Neutral PowerUp Acquisition Neutral SummaryPanbela Therapeutics beats PowerUp Acquisition on 4 of the 7 factors compared between the two stocks. Remove Ads Get Panbela Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PBLA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBLA vs. The Competition Export to ExcelMetricPanbela TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.89M$7.11B$5.74B$8.01BDividend YieldN/A2.77%4.41%4.10%P/E Ratio-0.016.2924.0519.08Price / SalesN/A229.66398.5087.44Price / CashN/A65.6738.1134.64Price / Book-0.026.506.824.32Net Income-$25.26M$141.58M$3.19B$247.06M7 Day PerformanceN/A-0.51%-0.23%0.83%1 Month Performance21.88%-8.15%-0.47%-9.31%1 Year Performance-38.10%-5.34%13.29%4.51% Panbela Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBLAPanbela TherapeuticsN/A$0.39-3.7%N/A-37.3%$1.89MN/A-0.016Upcoming EarningsGap DownPWUPPowerUp AcquisitionN/A$0.86flatN/A-94.2%$6.68MN/A0.00N/AHigh Trading VolumeCELZCreative Medical Technology0.4916 of 5 stars$3.82-8.0%N/A-42.8%$6.68M$11,000.00-1.015Gap DownHigh Trading VolumeAIMDAinos1.0794 of 5 stars$0.46-5.9%N/A-59.2%$6.48M$40,633.00-0.2840Gap DownVAXXVaxxinityN/A$0.05+49,900.0%N/A-100.0%$6.34MN/A-0.1190Gap UpENSCEnsysce Biosciences0.2328 of 5 stars$4.83-3.8%N/A-68.1%$6.31M$2.23M-0.1810Upcoming EarningsNews CoverageNLSPNLS PharmaceuticsN/A$1.70flatN/A+474.5%$6.12MN/A0.006Gap UpALBTAvalon GloboCare1.1182 of 5 stars$5.49-24.1%N/A-2.8%$6.01M$1.31M-0.285Gap DownPBMPsyence BiomedicalN/A$0.88-4.6%N/A-99.3%$5.80MN/A0.00N/ANews CoverageEVOKEvoke Pharma0.6989 of 5 stars$3.82-1.4%N/A-56.9%$5.68M$8.62M-0.354Earnings ReportShort Interest ↓SNGXSoligenix1.4378 of 5 stars$2.26-4.6%N/A-75.9%$5.67M$840,000.00-0.3020Upcoming EarningsGap Down Remove Ads Related Companies and Tools Related Companies PowerUp Acquisition Competitors Creative Medical Technology Competitors Ainos Competitors Vaxxinity Competitors Ensysce Biosciences Competitors NLS Pharmaceutics Competitors Avalon GloboCare Competitors Psyence Biomedical Competitors Evoke Pharma Competitors Soligenix Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PBLA) was last updated on 3/19/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Panbela Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Panbela Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
